The metabolic disorders drugs market covers medications that are used in the treatment of metabolic diseases such as diabetes, thyroid, hyperparathyroidism, hypopituitarism, and hypoadrenalism. Some of the major drugs used in the treatment of metabolic diseases are Insulin, Methimazole, and Calcimimetics.
The substantial growth of the market from $90 billion in 2017 to $124 billion by 2021 is due to the rapid growth of diabetic patients which, according to the World Health Organization, is expected to be the world’s seventh leading cause of death in 2030.
In the report, the global metabolic disorder drugs market is divided into three segments. Anti-diabetic drug occupy the major share, accounting for more than 95% of the market and the remaining share is occupied by the other segments, namely, anti-thyroid drugs and others (hyperparathyroidism, hypopituitarism, hypoadrenalism).
The USA was the largest country in the metabolic disorder drugs market in 2017, accounting for nearly 35% of the market share. This was mainly due to large diabetic population and strong demand for anti-diabetics drugs in the country. China and Germany followed the USA as the next largest countries in the market.
The metabolic disorder drugs market is fragmented with a number of large and small organizations. The top five competitors in the market made up more than 35% of the total market in 2017. Sanofi S.A. was the largest competitor of the market, followed by Novo Nordisk A/S, AstraZeneca Plc., Johnson & Johnson and Merck & Co. Sanofi is a global life sciences company focused on vaccines, rare diseases, multiple sclerosis, immunology, oncology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. The company was founded in 1994 and is headquartered in Paris, France.
About The Business Research Company.
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]